References
- Badie F, Arshadi M, Mohsenpoor M, Gharibvand SS. Drug
Resistance Pattern of Mycobacterium tuberculosis Isolates From Patients Referred
to TB Reference Laboratory in Ahvaz. Osong Public Health and Research Perspectives.
2016;7(1):32-35. PubMed | Google
Scholar
- Ao W, Aldous S, Woodruff E, Hicke B, Rea L, Kreiswirth
B, Jenison R. Rapid detection of rpoB gene mutations conferring rifampin resistance
in Mycobacterium tuberculosis. Journal of Clinical Microbiology. 2012; 50(7):2433-2440. PubMed | Google
Scholar
- GangulyJ, Ray S, Nandi S, Halder S, Kundu S, Mandal A. A Study To Evaluate Pattern of Rifampicin Resistance in Cases of Sputum Positive Pulmonary Tuberculosis. Journal of Evolution of Medical and Dental Sciences. 2015; 4(28): 4762-4768. PubMed | Google Scholar
- Hauck Y, Fabre M, Verguand G, Soler C, Pourcel C. Comparison
of two commercial assays for characterization of rpoB mutations in Mycobacterium
tuberculosis and description of new mutations conferring weak resistance to
rifampicin. J Antimicrobiol Chemother. 2009; 64(2):1-4. PubMed | Google
Scholar
- Farooqi J Q, Khan E, Alam S M Z, Ali A, Hasan Z, Hasan R. Line probe assay for detection of rifampicin and isoniazid resistant tuberculosis in Pakistan. The Journal of the Pakistan Medical Association. 2012; 62(8): 767-772. PubMed | Google Scholar
- Johnson R, Streicher E M, Louw G E, Warren R M, van Helden
P D, Victor T C. Drug resistance in Mycobacterium tuberculosis. Curr Issues
Mol Biol. 2006; 8(2): 97-112. PubMed | Google Scholar
- Somoskovi A, Parsons L M, Salfinger M. The molecular basis
of resistance to isoniazid, rifampicin and pyrazinamide in Mycobacterium tuberculosis.
Respir Res. 2001; 2(3): 164-168. PubMed | Google Scholar
- Abdella K, Abdissa K, Kebede W, Abebe G. Drug resistance
patterns of Mycobacterium tuberculosis complex and associated factors among
retreatment cases around Jimma, Southwest Ethiopia. BMC Public Health. 2015;
15: 599. PubMed | Google Scholar
- Miotto P, Cirillo D M, Migliori G B. Drug resistance in Mycobacterium tuberculosis: molecular mechanisms challenging fluoroquinolones and pyrazinamide effectiveness. Chest. 2015; 147(4): 1135-1143. PubMed | Google Scholar
- WHO.Global Tuberculosis Report 2014. Zhurnal Eksperimental?noi
I Teoreticheskoi Fiziki. 2014; 1-134. PubMed | Google Scholar
- WHO Global tuberculosis. Global
tuberculosis report 2016 Accessed 27/06/2017.
- World Health Organization. 2010. Multidrug and extensively drug-resistant TB (M/XDR-TB) 2010 Global report surveillance and response. Google Scholar
- World Health Organization. (2014). Xpert MTB / RIF implementation.WHO Manual Accessed 27/06/2017
- World Health Organization.Multidrug and extensively drug resistant tuberculosis Accessed 27/06/2017
- Ascp K J M. GeneXpert MTB / RIF Performance Characteristics in a State Public Health Laboratory Context.Pan Afr Med J. 2016; 25: 129. PubMed | Google Scholar
- Ocheretina O, Escuyer,V E, Mabou M M, Royal-Mardi G, Collins S, Vilbrun S C, Fitzgerald D W. Correlation between genotypic and phenotypic testing for resistance to rifampin in Mycobacterium tuberculosis clinical isolates in Haiti: investigation of cases with discrepant susceptibility results. PLoS ONE. 2014; 9(3):e90569. PubMed | Google Scholar
- Telenti A P, Imboden P, Marchesi F, Lowrie D, Cole M, Colston M J, Matter L, Schopfer K, Bodmer T. Detection of rifampicin resistance mutations in Mycobacterium tuberculosis. Lancet. 1993; 341(8846): 647-650. PubMed | Google Scholar
- Rufai S B, Kumar P, Singh A, Prajapati S, Balooni V, Singh S. Comparison of xpert MTB/RIF with line probe assay for detection of rifampin-monoresistant Mycobacterium tuberculosis.Journal of Clinical Microbiology. 2014; 52(6): 1846-1852. PubMed | Google Scholar
- Hoshide M, Quan L, Rodrigues C, Warren R, Victor T, EvascoH B, Tupasi T, Crudu V, DouglasJ T. Geographical Differences Associated with SNPs in Nine Gene Targets among Resistant Clinical Isolates of Mycobacterium tuberculosis. J Clin Microbiol. 2013 Nov;51(11):3913. PubMed | Google Scholar
- Racheal S D M, Zephaniah D, Reggie M, Kerina D, Babill S P, Peter M. Diagnosis of multi-drug resistant tuberculosis mutations using Hain line probe assay and GeneXpert: a study done in Zimbabwe. British Journal of Medicine and Medical Research. 2015; 5(8):1044-1052. PubMed | Google Scholar
- Metcalfe J Z, Makumbirofa S, MakamureB, Sandy C, Bara W, Mungofa S, Hopewell PC, Mason P. Drug-resistant tuberculosis in High risk groups Zimbabwe. Emerging infectious diseases. 2014; 20(1): 135-138. PubMed | Google Scholar
- Torres J N, Paul L V, Rodwell T C, Victor T C, Amallraja
A M, Elghraoui A,Valafar F. Novel katG mutations causing isoniazid resistance
in clinical M: tuberculosis isolates. Emerging Microbes & Infections. 2015; 4(April): e42. PubMed | Google Scholar
- Rahman A, Sahrin M, Afrin S, Earley K, Ahmed S. Comparison of Xpert MTB / RIF Assay and GenoType MTBDR plus DNA Probes for Detection of Mutations Associated with Rifampicin Resistance. Mycobacterium tuberculosis. 2016; 11(4): 1-11. PubMed | Google Scholar
- Biadglegne F, Tessema B, Rodloff A C, Sack U. Magnitude
of gene mutations conferring drug resistance in Mycobacterium tuberculosis
isolates from lymph node aspirates in ethiopia. International Journal of Medical
Sciences. 2013; 10(11): 1589-1594. PubMed | Google Scholar
- Mohajeri P, Sadri H, Farahani A, Norozi B, Atashi S. Frequency of Mutations Associated with Rifampicin Resistance in Mycobacterium tuberculosis Strains Isolated from Patients in West of Iran. Microbial Drug Resistance (Larchmont, NY). 2015; 21(3): 315-319. PubMed | Google Scholar
- Osman M, Simpson J A, Caldwell J, Bosman M, Nicol M P.
GeneXpert MTB/RIF version g4 for identification of rifampin-resistant tuberculosis
in a programmatic setting. Journal of Clinical Microbiology. 2014; 52(2): 635-637. PubMed | Google Scholar
- Ahmad S, Al-Mutairi N M, Mokaddas E. Variations in the occurrence of specific rpoB mutations in rifampicin resistant Mycobacterium tuberculosis isolates from patients of different ethnic groups in Kuwait. Indian Journal of Medical Research. 2012; 135(5):756-762. PubMed | Google Scholar
- Doustdar F, Khosravi A D, Farnia P, Bahrmand A R, Masjedi M R, Velayati A A. Mutations in rpoB gene and genotypes of rifampin resistant Mycobacterium tuberculosis isolates in Iran. Tanaffos. 2008; 7(2): 11-17. PubMed | Google Scholar
- Tadesse M, Aragaw D, Dimah B, Efa F, Abdella K, Kebede W, Abebe G. Drug resistance-conferring mutations in Mycobacterium tuberculosis from pulmonary tuberculosis patients in Southwest Ethiopia. International Journal of Mycobacteriology. 2016; 5(2): 185-191. PubMed | Google Scholar
- Ganguly J, Ray S, Nandi S, Halder S, KunduS, Mandal A. A Study To Evaluate Pattern of Rifampicin Resistance in Cases of Sputum Positive Pulmonary Tuberculosis. Journal of Evolution of Medical and Dental Sciences. 2015; 4(28): 4762-4768. PubMed | Google Scholar
- Minh N N, Van Bac N, Son N T, Lien V T K, Ha C H, Cuong N H, Le T H. Molecular characteristics of rifampin- and isoniazid-resistant Mycobacterium tuberculosis strains isolated in Vietnam. Journal of Clinical Microbiology. 2012; 50(3):598-601. PubMed | Google Scholar
- Pang Y, Lu J, Wang Y, Song Y, Wang S, Zhao Y. Study of the rifampin monoresistance mechanism in Mycobacterium tuberculosis. Antimicrobial Agents and Chemotherapy. 2013; 57(2): 893-900. PubMed | Google Scholar
- Van Deun A, Aung KJ M, Hossain M A, De Rijk P, Gumusboga M, Rigouts L, De Jong B C. Disputed rpoB mutations can frequently cause important rifampicin resistance among new tuberculosis patients. International Journal of Tuberculosis and Lung Disease. 2015; 19(2):185-190. PubMed | Google Scholar
- Van Deun A, Barrera L, Bastian I, Fattorini L, Hoffmann H, Kam KM, Wright A. Mycobacterium tuberculosis strains with highly discordant rifampin susceptibility test results. Journal of Clinical Microbiology. 2009; 47(11):3501-3506. PubMed | Google Scholar
- Mani C, Selvakumar N, Narayanan S, Narayanan PR. Mutations in the rpoB gene of multidrug- resistant Mycobacterium tuberculosis clinical isolates from India. J Clin Microbiol. 2001; 39(8):2987-2990. PubMed | Google Scholar
- Wang S, Zhao B, Song Y, Zhou Y, Pang Y, Ou X, Li Q. Molecular characterization of the rpoB gene mutations of Mycobacterium tuberculosis isolated from China. J Clin Microbiol. 2013; 1(1): 1-8. PubMed | Google Scholar
- Kumar P, Kumar P, Balooni V, Singh S. Genetic mutations associated with rifampicin and isoniazid resistance in MDR-TB patients in North-West India. International Journal of Tuberculosis and Lung Disease. 2015; 19(4): 434-439. PubMed | Google Scholar
- Metchock B, Abmm D. New TB Diagnostic Tools and the Challenges of Interpreting Discordant Results. Lung India. July2012; 43 (9): 1-43. PubMed | Google Scholar
- N'guessan Kouassi K, Riccardo A, Dutoziet ChristianC, André G, Férilaha C, Hortense SA,Mireille D. Genotyping of mutations detected with GeneXpert. International Journal of Mycobacteriology. 2016; 5(2):142-147. PubMed | Google Scholar
- Pang Y, Lu J, Wang Y, Song Y, Wang S, Zhao Y. Study of
the rifampin monoresistance mechanism in Mycobacterium tuberculosis. Antimicrobial
Agents and Chemotherapy. 2013; 57(2): 893-900. PubMed | Google Scholar
- Rigouts L, Gumusboga M, De Rijk W B, Nduwamahoro E, Uwizeye C, De Jong B, Van Deun A. Rifampin resistance missed in automated liquid culture system for Mycobacterium tuberculosis isolates with specific rpoB mutations. Journal of Clinical Microbiology. 2013; 51(8):2641-2645. PubMed | Google Scholar
- Blakemore R. Evaluation of the analytical performance
of the Xpert MTB/RIF assay. J Clin Microbiol. 2010; 48(7): 2495-2501. PubMed | Google Scholar
- Zhang M, Yue J, Yang Y, Zhang H M, Lei J Q, Jin R L,
Zhang X L, Wang H H. Detection of mutation associated with isoniazid resistance
in Mycobacterium tuberculosis isolates from China. J Clin Microbiol. 2005;
43(11):5477-5482. PubMed | Google Scholar
- Green E, Obi C L, De Villiers B E, Sein P P, Letsoalo T, Hoosen AA, Bessong PO. Molecular characterization of resistant Mycobacterium tuberculosis from Dr George Mukhari hospital, Pretoria, South Africa. South Afr, J Epidemiol Infect. 2008; 23(3):11-14. PubMed | Google Scholar
- Boakye-Appiah J K, Steinmetz A R, Pupulampu P, Ofori-Yirenkyi S, Tetteh I, Frimpong M, Phillips RO. High prevalence of multidrug-resistant tuberculosis among patients with rifampicin resistance using GeneXpert Mycobacterium tuberculosis/rifampicin in Ghana. International Journal of Mycobacteriology. 2016; 5(2): 226-230. PubMed | Google Scholar
- Doustdar F, Khosravi A D, Farnia P, Bahrmand A R, Masjedi M R, Velayati A A. Mutations in rpoB gene and genotypes of rifampin resistant Mycobacterium tuberculosis isolates in Iran. Tanaffos. 2008; 7(2): 11-17. PubMed | Google Scholar
- Jain A, Mondal R. Extensively drug resistant tuberculosis: current challenges and threats. FEMS Immunol Med Microbiol. 2008; (53):145-150. PubMed | Google Scholar
- Khan M M, Alves M S, Ali S, Sherwani S K, Baig M A, Siddiqui A A, Kamal M. Depiction of new mutations in the rpoB gene associated with rifampin resistance in clinical isolates of Mycobacterium tuberculosis. BMC Infect Dis. 2013; 4(11): 1723-1727. PubMed | Google Scholar